General Information of the Protein
Protein ID
PT05580
Protein Name
Proton-coupled folate transporter
Secondarily
Protein Name
Heme carrier protein 1
PCFT/HCP1
Solute carrier family 46 member 1
Gene Name
SLC46A1
Secondarily
Gene Name
G21
HCP1
PCFT
Sequence
MEGSASPPEKPRARPAAAVLCRGPVEPLVFLANFALVLQGPLTTQYLWHRFSADLGYNGTRQRGGCSNRSADPTMQEVETLTSHWTLYMNVGGFLVGLFSSTLLGAWSDSVGRRPLLVLASLGLLLQALVSVFVVQLQLHVGYFVLGRILCALLGDFGGLLAASFASVADVSSSRSRTFRMALLEASIGVAGMLASLLGGHWLRAQGYANPFWLALALLIAMTLYAAFCFGETLKEPKSTRLFTFRHHRSIVQLYVAPAPEKSRKHLALYSLAIFVVITVHFGAQDILTLYELSTPLCWDSKLIGYGSAAQHLPYLTSLLALKLLQYCLADAWVAEIGLAFNILGMVVFAFATITPLMFTGYGLLFLSLVITPVIRAKLSKLVRETEQGALFSAVACVNSLAMLTASGIFNSLYPATLNFMKGFPFLLGAGLLLIPAVLIGMLEKADPHLEFQQFPQSP
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Transporter
>
Electrochemical transporter
>
SLC superfamily of solute carriers
>
SLC46 family of folate transporters
Function
Proton-coupled folate symporter that mediates folate absorption using an H(+) gradient as a driving force (PubMed:17129779, PubMed:17446347, PubMed:17475902, PubMed:19389703, PubMed:19762432, PubMed:25504888, PubMed:30858177, PubMed:31792273, PubMed:34619546, PubMed:29344585, PubMed:31494288, PubMed:32893190). Involved in the intestinal absorption of folates at the brush-border membrane of the proximal jejunum, and the transport from blood to cerebrospinal fluid across the choroid plexus (PubMed:17129779, PubMed:17446347, PubMed:17475902, PubMed:19389703, PubMed:25504888, PubMed:30858177, PubMed:29344585, PubMed:31494288, PubMed:32893190). Functions at acidic pH via alternate outward- and inward-open conformation states (PubMed:34040256, PubMed:32893190). Protonation of residues in the outward open state primes the protein for transport (PubMed:34040256). Binding of folate promotes breaking of salt bridge network and subsequent closure of the extracellular gate, leading to the inward-open state and release of protons and folate (PubMed:34040256). Also able to transport antifolate drugs, such as methotrexate and pemetrexed, which are established treatments for cancer and autoimmune diseases (PubMed:18524888, PubMed:19762432, PubMed:25608532, PubMed:28802835, PubMed:29326243, PubMed:34619546, PubMed:34040256, PubMed:22345511). Involved in FOLR1-mediated endocytosis by serving as a route of export of folates from acidified endosomes (PubMed:19074442). Also acts as a lower-affinity, pH-independent heme carrier protein and constitutes the main importer of heme in the intestine (PubMed:17156779). Imports heme in the retina and retinal pigment epithelium, in neurons of the hippocampus, in hepatocytes and in the renal epithelial cells (PubMed:32621820). Hence, participates in the trafficking of heme and increases intracellular iron content (PubMed:32621820).
    Show/Hide
Uniprot ID
Primary ID:
Q96NT5

Secondarily ID:
Q1HE20
Q86T92
Q8TEG3
Q96FL0
    Show/Hide
Ensembl ID
ENSG00000076351
HGNC ID
HGNC:30521
Subcellular Location
Cell membrane
Apical cell membrane
Basolateral cell membrane
Endosome membrane
Cytoplasm
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000330 , CHO Pro-4 MtxRII OuaR-2-4
Compound ID Compound Name Compound Formula
CP0915865
(5-(3-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)propyl)thiophene-3-carbonyl)-L-glutamic acid
   Show/Hide
C19H20N4O6S2
 1
1
IC50 = 80.45 nM
   TI
   LI
   LO
   TS
CP0958003
(4-(3-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)propyl)thiophene-2-carbonyl)-L-glutamic acid
   Show/Hide
C19H20N4O6S2
 1
1
IC50 = 107.29 nM
   TI
   LI
   LO
   TS
CP0915864
(4-(4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl)thiophene-2-carbonyl)-L-glutamic acid
   Show/Hide
C20H22N4O6S2
 1
1
IC50 = 460.21 nM
   TI
   LI
   LO
   TS
CP0035062
(S)-2-(4-(4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl)benzamido)pentanedioic acid
   Show/Hide
C22H24N4O6S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0882698
(5-(4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl)thiophene-3-carbonyl)-L-glutamic acid
   Show/Hide
C20H22N4O6S2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0915862
(5-(4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl)thiophene-2-carbonyl)-L-glutamic acid
   Show/Hide
C20H22N4O6S2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0915863
(5-(3-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)propyl)thiophene-2-carbonyl)-L-glutamic acid
   Show/Hide
C19H20N4O6S2
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0915866
(5-(4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl)furan-2-carbonyl)-L-glutamic acid
   Show/Hide
C20H22N4O7S
 1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
CP0036368
(2S)-2-{[4-(2-{2-amino-4-oxo-1H,4H,7H-pyrrolo[2,3-d]pyrimidin-5-yl}ethyl)phenyl]formamido}pentanedioic acid
   Show/Hide
C20H21N5O6
 4
1
Ki = 94 nM
   TI
   LI
   LO
   TS
2
Ki = 96 nM
   TI
   LI
   LO
   TS
3
Ki = 1540 nM
   TI
   LI
   LO
   TS
4
Ki = 2540 nM
   TI
   LI
   LO
   TS
CP0204133
(S)-2-({5-[5-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]-pyrimidin-6-yl)-pentyl]-thiophene-2-carbonyl}-amino)-pentanedioicAcid
   Show/Hide
C21H25N5O6S
 2
1
Ki = 100 nM
   TI
   LI
   LO
   TS
2
Ki = 2230 nM
   TI
   LI
   LO
   TS
CP0330758
(S)-2-({5-[4-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]-pyrimidin-6-yl)-butyl]-thiophene-2-carbonyl}-amino)-pentanedioicAcid
   Show/Hide
C20H23N5O6S
 4
1
Ki = 130 nM
   TI
   LI
   LO
   TS
2
Ki = 230 nM
   TI
   LI
   LO
   TS
3
Ki = 1950 nM
   TI
   LI
   LO
   TS
4
Ki = 7230 nM
   TI
   LI
   LO
   TS
CP0387048
(2S)-2-[[4-[4-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-6-yl)butyl]thiophene-2-carbonyl]amino]pentanedioic acid
   Show/Hide
C20H23N5O6S
 2
1
Ki = 390 nM
   TI
   LI
   LO
   TS
2
Ki = 28100 nM
   TI
   LI
   LO
   TS
CP0260881
(2S)-2-[[5-[4-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-6-yl)butyl]thiophene-3-carbonyl]amino]pentanedioic acid
   Show/Hide
C20H23N5O6S
 2
1
Ki = 420 nM
   TI
   LI
   LO
   TS
2
Ki = 30700 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( Proton-coupled folate transporter (SLC46A1) )
Target Type Successful Target
Disease 2 Target-related Diseases  2
1 Vitamin deficiency [ICD-11: 5B55-5B71]
2 leukaemia [ICD-11: 2A60-2B33]
Approved Drug(s) 2 Approved Drugs  2
1 Folic Acid Approved
Vitamin deficiency
2 Methotrexate Approved
leukaemia